Cargando…

Current practice in the diagnosis and management of sarcopenia and frailty – results from a UK-wide survey

OBJECTIVES: Despite a rising clinical and research profile, there is limited information about how frailty and sarcopenia are diagnosed and managed in clinical practice. Our objective was to build a picture of current practice by conducting a survey of UK healthcare professionals. METHODS: We survey...

Descripción completa

Detalles Bibliográficos
Autores principales: Offord, Natalie J., Clegg, Andrew, Turner, Gill, Dodds, Richard M., Sayer, Avan A., Witham, Miles D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: HYLONOME PUBLICATIONS 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155363/
https://www.ncbi.nlm.nih.gov/pubmed/32300721
http://dx.doi.org/10.22540/JFSF-04-071
Descripción
Sumario:OBJECTIVES: Despite a rising clinical and research profile, there is limited information about how frailty and sarcopenia are diagnosed and managed in clinical practice. Our objective was to build a picture of current practice by conducting a survey of UK healthcare professionals. METHODS: We surveyed healthcare professionals in NHS organisations, using a series of four questionnaires. These focussed on the diagnosis and management of sarcopenia, and the diagnosis and management of frailty in acute medical units, community settings and surgical units. RESULTS: Response rates ranged from 49/177 (28%) organisations for the sarcopenia questionnaire to 104/177 (59%) for the surgical unit questionnaire. Less than half of responding organisations identified sarcopenia; few made the diagnosis using a recognised algorithm or offered resistance training. The commonest tools used to identify frailty were the Rockwood Clinical Frailty Scale or presence of a frailty syndrome. Comprehensive Geriatric Assessment was offered by the majority of organisations, but this included exercise therapy in less than half of cases, and medication review in only one-third to two-thirds of cases. CONCLUSIONS: Opportunities exist to improve consistency of diagnosis and delivery of evidence-based interventions for both sarcopenia and frailty.